Global Retirement Partners’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Global Retirement Partners’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$3.2K	Sell	70 -70	-50%	-$3.1K	﹤0.01%	3576
2025 Q3	$5.46K	Buy	140 +70	+100%	+$2.54K	﹤0.01%	2944
2025 Q2	$2.37K	Buy	+70	New	+$2.22K	﹤0.01%	3182
2024 Q4	$2.73K	Buy	+70	New	+$2.94K	﹤0.01%	2958

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Global Retirement Partners's GNOM Position: Q4 2025 in Review

Global Retirement Partners reduced its Global X Genomics & Biotechnology ETF (GNOM) stake by 50% in Q4 2025, selling an estimated $3.1K and leaving 70 shares worth $3.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3576.

Global Retirement Partners first reported a position in GNOM in Q4 2024 and has held it in 4 quarters since. The position peaked at $5.46K in Q3 2025. 40 funds tracked by Wall St. Rank hold GNOM as of Q4 2025.

Global Retirement Partners held 70 shares of Global X Genomics & Biotechnology ETF worth $3.2K as of Q4 2025.
Global Retirement Partners sold 70 Global X Genomics & Biotechnology ETF shares in Q4 2025, an estimated $3.1K.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3576 holding.
Global Retirement Partners first reported a position in Global X Genomics & Biotechnology ETF in Q4 2024 and has held it in 4 quarters since.
Global Retirement Partners's Global X Genomics & Biotechnology ETF position peaked at $5.46K in Q3 2025.
40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.